Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of an Adapted Physical Activity Program on Event-free Survival in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line

NCT04670029 is registered in ClinicalTrials.gov with Weprom as lead sponsor.

NCT NCT04670029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04670029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of an Adapted Physical Activity Program on Event-free Survival in Patients With Diffuse Large-cell B Lymphoma Treated in 1st Line
Lead sponsor
Weprom
Phase
Phase 3
Overall status
Recruiting
Start date
September 8, 2021
Completion date
February 28, 2029
Enrollment
186 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma